Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
The chemerin/CMKLR1 axis regulates intestinal graft-versus-host disease
Erica Dander, Paola Vinci, Stefania Vetrano, Camilla Recordati, Rocco Piazza, Grazia Fazio, Donatella Bardelli, Mattia Bugatti, Francesca Sozio, Andrea Piontini, Sonia Bonanomi, Luca Bertola, Elena Tassistro, Maria Grazia Valsecchi, Stefano Calza, William Vermi, Andrea Biondi, Annalisa Del Prete, Silvano Sozzani, Giovanna D’Amico
Erica Dander, Paola Vinci, Stefania Vetrano, Camilla Recordati, Rocco Piazza, Grazia Fazio, Donatella Bardelli, Mattia Bugatti, Francesca Sozio, Andrea Piontini, Sonia Bonanomi, Luca Bertola, Elena Tassistro, Maria Grazia Valsecchi, Stefano Calza, William Vermi, Andrea Biondi, Annalisa Del Prete, Silvano Sozzani, Giovanna D’Amico
View: Text | PDF
Research Article Immunology Transplantation

The chemerin/CMKLR1 axis regulates intestinal graft-versus-host disease

  • Text
  • PDF
Abstract

Gastrointestinal graft-versus-host disease (GvHD) is a major cause of mortality and morbidity following allogeneic bone marrow transplantation (allo-BMT). Chemerin is a chemotactic protein that recruits leukocytes to inflamed tissues by interacting with ChemR23/CMKLR1, a chemotactic receptor expressed by leukocytes, including macrophages. During acute GvHD, chemerin plasma levels were strongly increased in allo-BM-transplanted mice. The role of the chemerin/CMKLR1 axis in GvHD was investigated using Cmklr1-KO mice. WT mice transplanted with an allogeneic graft from Cmklr1-KO donors (t-KO) had worse survival and more severe GvHD. Histological analysis demonstrated that the gastrointestinal tract was the organ mostly affected by GvHD in t-KO mice. The severe colitis of t-KO mice was characterized by massive neutrophil infiltration and tissue damage associated with bacterial translocation and exacerbated inflammation. Similarly, Cmklr1-KO recipient mice showed increased intestinal pathology in both allogeneic transplant and dextran sulfate sodium–induced colitis. Notably, the adoptive transfer of WT monocytes into t-KO mice mitigated GvHD manifestations by decreasing gut inflammation and T cell activation. In patients, higher chemerin serum levels were predictive of GvHD development. Overall, these results suggest that CMKLR1/chemerin may be a protective pathway for the control of intestinal inflammation and tissue damage in GvHD.

Authors

Erica Dander, Paola Vinci, Stefania Vetrano, Camilla Recordati, Rocco Piazza, Grazia Fazio, Donatella Bardelli, Mattia Bugatti, Francesca Sozio, Andrea Piontini, Sonia Bonanomi, Luca Bertola, Elena Tassistro, Maria Grazia Valsecchi, Stefano Calza, William Vermi, Andrea Biondi, Annalisa Del Prete, Silvano Sozzani, Giovanna D’Amico

×

Figure 1

Analysis of chemerin plasma levels and CMKLR1+ cells in mice after BMT.

Options: View larger image (or click on image) Download as PowerPoint
Analysis of chemerin plasma levels and CMKLR1+ cells in mice after BMT.
...
Lethally irradiated BALB/c (H-2d) mice were transplanted with bone marrow and splenocytes obtained from C57BL/6 WT mice (t-WT, H-2b) or BALB/c mice (SYN, H-2d). (A) Chemerin plasma concentrations were analyzed by ELISA before the conditioning regimen and after BMT at different time points in allogeneic-transplanted mice and syngeneic-transplanted mice. Data are shown as mean ± SEM (n ≥ 3), and results are pooled from 2 independent experiments. *Adjusted P value < 0.05, Mann-Whitney test with Bonferroni-Dunn correction for multiple comparisons. (B) To localize CMKLR1+ cells, mouse tissues were analyzed with RNAscope assay. Sections from mouse spleen, colon, ileum, and liver of SYN and allogeneic-transplanted mice were stained for Cmklr1 mRNA. Original magnification, ×400; scale bars: 50 μm. (C) Cmklr1 transcript (RNAscope, red) was observed in IBA1+ macrophages (immunohistochemistry, blue) including liver Kupffer cells. Original magnification, ×600; scale bar: 33 μm. (D) The identity of chemerin-producing cells was investigated by RNAscope staining of Rarres2 mRNA. Rarres2 staining (red signal) was observed in IBA1+ macrophages (immunohistochemistry, blue) and in claudin-5–positive (CL5+) endothelial cells (immunohistochemistry, blue; arrowheads, CL5+ endothelial cells). Original magnification, ×600; scale bar: 33 μm.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts